Frontiers in Cardiovascular Medicine

DECEMBER 13, 2023

Imaging techniques and modeling technology allow a more personalized strategy for each patient. In this case, we present a symptomatic patient with a Kommerell's diverticulum and a left aberrant subclavian artery complicated by proximal stenosis and poststenotic aneurysm.

Stents 75

Stents Stent Stenosis Aneurysm 75

DAIC

APRIL 25, 2024

Aortic stenosis is a narrowing of the aortic valve which prevents the aortic leaflets from opening and closing properly. Patients with aortic stenosis often have heart murmurs and experience debilitating symptoms including chest pain, dizziness, fatigue, shortness of breath and an irregular heartbeat.

Heart Valves 59

Heart Valves Stenosis Aortic Aortic valve 59

DAIC

FEBRUARY 26, 2025

a provider of AI technology for coronary artery disease (CAD) management, recently introduced its new brand identity reflecting its focus on delivering clarity, precision and confidence in the prevention, diagnosisand treatment of CAD. tim.hodson Wed, 02/26/2025 - 10:24 Feb. 25, 2025 Heartflow, Inc. , In the U.S.,

Coronary Artery Disease 59

Coronary Artery Disease Heart attacks Heart Attack Technology 59

DAIC

JANUARY 4, 2024

In all cases, patients achieved complete resolution of aortic disease with no residual stenosis or regurgitation immediately following the procedure, and all patients were discharged within 24-48 hours of the procedure. Additionally, by fluoroscopy, all implanted ZETA valves were consistently implanted within two millimeters of the annulus.

Aortic valve 105

Aortic valve Heart Valves Aortic Technology 105

DAIC

FEBRUARY 20, 2024

mm (green outline) section thickness show the respective calcified plaque (arrowheads) and coronary stenosis (inset images). The reduced section thickness leads to less calcium blooming and therefore a less severe assessment of percentage of coronary stenosis in this patient. Curved multiplanar reconstructions with 0.6-mm

Coronary Artery Disease 105

Coronary Artery Disease Stenosis Plaque Technology 105

Cassling

OCTOBER 14, 2024

510(k) clearance secured from FDA allows for EIQ’s AI-enabled solution, EchoSolv AS, to be marketed and sold in the USA Clearance marks a major milestone and will allow for rapid commercial scale-up EIQ is in advanced discussions with a range of US healthcare providers around the potential uptake of EchoSolv AS Working alongside US consultancy to obtain (..)

Reimbursement 98

Reimbursement Stenosis Technology Aortic 98

DAIC

JANUARY 17, 2024

With the continuous progress of science and technology, artificial intelligence (AI) has become an important driving force for a new round of scientific and technological revolution and industrial change.

Technology 111

Technology Coronary Artery Disease Cardiovascular Disease Cardiovascular Imaging 111

DAIC

MARCH 11, 2025

The CaRi-Plaque technology supports non-invasive analysis of coronary anatomy and pathology from routine coronary computed tomography angiography (CCTA) scans to determine the presence, extent and severity of coronary plaques and luminal stenosis (narrowing of arteries).

Plaque 52

Plaque Heart attacks Heart Attack Technology 52

Frontiers in Cardiovascular Medicine

AUGUST 7, 2024

Aortic Stenosis (AS) is a common condition with an estimated pooled prevalence of all AS in the elderly population at around 12.4%, with that of severe AS estimated to be around 3.4%. In the past, surgical aortic valve replacement was the primary treatment option for severe AS for decades.

Aortic valve 98

Aortic valve Aortic TAVR Peripheral Arterial Disease 98

DAIC

NOVEMBER 8, 2024

Developing and driving clinical evidence is crucial to improving care and guiding the adoption of new technologies like the Philips laser atherectomy and lithotripsy system,” said Drs. The care team there successfully treated a 78-year-old male with peripheral vascular disease using the Philips device. Patients will be followed for 12 months.

Innovation 52

Innovation Peripheral Arterial Disease Technology Ultrasound 52

DAIC

JUNE 18, 2024

The designation recognizes the novelty of the technology and the potential to provide a more effective treatment option for patients with coronary artery disease. 3 “We very much appreciate FDA’s breakthrough designation recognition of the bioadaptor technology,” continued Sirhan. Food and Drug Administration (FDA). of the U.S.

Coronary Artery Disease 105

Coronary Artery Disease Technology Stents Stent 105

DAIC

MARCH 10, 2025

tim.hodson Mon, 03/10/2025 - 11:17 At the Cardiovascular Research Technologies (CRT) 2025 conference in Washington, D.C., The analysis of data from SCAARon the Prevail coronary paclitaxel drug-coated balloon (DCB) will be presented as a late-breaking clinical trial at Cardiovascular Research Technologies (CRT) 2025 in Washington, D.C.

Blood Pressure 52

Blood Pressure Aortic Medicare Hypertension 52

DAIC

JANUARY 25, 2024

mg tablets), together with Caristo Diagnostics , a leading cardiac disease diagnostics company with the novel CaRi-Heart technology to visualize and quantify coronary inflammation, announced today their collaboration to improve awareness and clinical education about the central role of inflammation in coronary artery disease. mg tablets.”

Heart attacks 110

Heart attacks Heart Attack Technology Cardiovascular Disease 110

DAIC

MARCH 6, 2024

The CAD Staging System is a noninvasive imaging-based investigational software device that analyzes important and actionable features of coronary atherosclerosis, stenosis and ischemia. Cleerly is committed to accelerating the availability of its technology to healthcare providers and patients alike.

Heart Disease 105

Heart Disease Heart attacks Heart Attack Technology 105

Stroke Journal

JANUARY 21, 2024

Intracranial atherosclerotic disease and resultant intracranial stenosis is a global leading cause of stroke, and poses an ongoing treatment challenge. Among patients with intracranial stenosis, those with hemodynamic compromise are at high risk for recurrent stroke despite medical therapy and risk factor modification.

Stenosis 40

Stenosis Risk Factors Technology Strokes 40

DAIC

MARCH 28, 2024

The study describes the validation of Cleerly's artificial intelligence-guided quantitative coronary CT angiography (AI-QCT) ISCHEMIA technology for diagnostic accuracy and prognostic risk stratification.

Ischemia 110

Ischemia Chest Pain Atherosclerosis Coronary Artery Disease 110

DAIC

APRIL 23, 2024

milla1cf Tue, 04/23/2024 - 15:53 April 23, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest innovation in cardiac surgery, the Avalus Ultra valve. This next-generation surgical aortic tissue valve is designed to facilitate ease of use at implant and lifetime patient management.

Aortic valve 111

Aortic valve Aortic Innovation Cardiothoracic 111

Stroke Journal

JANUARY 21, 2024

The risk of stroke recurrence among patients with ICAD-related stroke is the highest among those with confirmed stroke and stenosis ≥70%. In fact, the 1-year recurrent stroke rate of >20% among those with stenosis >70% is one of the highest rates among common causes of stroke.

Stenosis 74

Stenosis Thrombosis Dementia Embolism 74

DAIC

JUNE 13, 2024

Getty Images milla1cf Thu, 06/13/2024 - 20:38 June 13, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest innovation in cardiac surgery, the Avalus Ultra valve. More specifically, the Avalus Ultra surgical valve has: A low valve profile designed to facilitate ease of use at implant.1,2

Aortic valve 109

Aortic valve Aortic Innovation Cardiothoracic 109

DAIC

MAY 8, 2024

2-4 HeartFlow’s non-invasive FFR CT technology has emerged as a leading frontline strategy for accurately diagnosing hemodynamically significant coronary lesions in patients suspected of having CAD. 5 Revascularization to improve blood flow to the heart has been shown to reduce mortality in stable chest pain patients.

Coronary Artery Disease 111

Coronary Artery Disease Chest Pain Ischemia Myocardial Infarction 111

CardiacWire

JULY 28, 2024

Edwards Lifesciences is going all-in on structural heart and heart failure, acquiring aortic valve-maker JenaValve Technology and implantable heart failure monitor company Endotronix for $1.2B and up to $445M in milestone payments.

Heart Failure 59

Heart Failure Aortic TAVR Critical Care 59

DAIC

JUNE 4, 2024

The Neuroguard Integrated Embolic Protection (IEP) system is an experimental treatment for carotid artery stenosis, also known as carotid artery disease, a condition in which fatty-waxy deposits known as plaque builds up and blocks the normal flow of blood in the large arteries on either side of the neck. Designed by Raleigh, N.C.-based

Stents 111

Stents Stent Research Stroke 111

DAIC

JUNE 3, 2024

Every year, approximately 300,000 cardiac patients in the United States are diagnosed with severe aortic stenosis, with only 28% receiving a TAVR, leaving the majority untreated. It further reported that, in 2011, Morristown Medical Center was the first in New Jersey to offer TAVR for severe aortic stenosis. million people.

TAVR 105

TAVR Aortic valve Aortic Hospital 105

DAIC

FEBRUARY 13, 2024

According to the company, Earls is a leader within the field of radiology and specializes in applications of advanced imaging technologies in cardiovascular care. He is the author of over 150 articles, book chapters, abstracts and other publications on advanced imaging technologies. Earls, MD , Chief Medical Officer of Cleerly.

Coronary Artery Disease 103

Coronary Artery Disease Ischemia Atherosclerosis Cardiovascular Imaging 103

DAIC

FEBRUARY 15, 2024

Abbott recognized the unmet need for people with this condition and explored the use of our proven clip-based technology to find a truly life-changing intervention. Advances in Transcatheter Tricuspid Valve Technologies VIDEO: Tricuspid Device Clinical Trial Overview — Interview with Ori Ben-Yehuda, M.D.

Tricuspid 102

Tricuspid Heart Valves Quality of Life Bicuspid/Mitral 102

DAIC

APRIL 2, 2024

It further reported that MHIF led the way as the first to provide this technology to a patient as part of an early research study in 2017 and completed the first-in-the-world enrollment in the pivotal trial in August 2019. TR occurs when the valve doesn't close properly, causing a leak and allowing blood to flow backward in the heart.

Tricuspid 105

Tricuspid Heart Valves Quality of Life Open-Heart Surgery 105

Frontiers in Cardiovascular Medicine

JULY 25, 2024

The past five years have yielded impressive advancements in fully absorbable metal stent technology. The desired ultimate ability for such devices to treat a vascular stenosis without long-term device-related complications or impeding future treatment continues to evoke excitement in clinicians and engineers alike.

Stents 52

Stents Stent Pediatrics Congenital Heart Disease 52

DAIC

JANUARY 31, 2024

In the written statement, he added, "A high bar has been set by performance of the system in clinical and commercial settings – where more than 40,000 patients have been treated to date – and we look forward to continuing to lead the way with this differentiated technology in the growing PFA space."

Ablation 111

Ablation Atrial Fibrillation Anatomy Pulmonary 111

DAIC

MARCH 12, 2024

milla1cf Tue, 03/12/2024 - 16:48 March 12, 2024 — Medtronic plc , a global leader in healthcare technology, today announced two late-breaking data presentations on four-year outcomes from the Evolut Low Risk Trial. At Medtronic, we continue to emphasize that valve design matters. mmHg TAVR; 11.8

TAVR 52

TAVR Aortic valve Aortic Stenosis 52

All About Cardiovascular System and Disorders

MAY 19, 2024

Transcatheter aortic valve replacement (TAVR) is increasing in popularity for symptomatic severe aortic stenosis. Brachiocephalic artery access without sternotomy for TAVR has been described as a Cutting-Edge Technology in a paper which has been just accepted in the JACC Asia [1].

Aortic valve 40

Aortic valve Aortic TAVR Open-Heart Surgery 40

DAIC

MAY 18, 2024

Recent technological advancements, such as catheter design and energy delivery, can pave the way for the wider adoption of PFA in clinical practice to improve patient outcomes. Compared to traditional thermal catheter ablation, the FARAPULSE PFA System requires a significantly shorter duration of energy application.

Heart Rhythm 105

Heart Rhythm Atrial Fibrillation Ablation Quality of Life 105

ADN Center of Excellence

SEPTEMBER 26, 2024

Looking Ahead As TAVI continues to evolve and play a crucial role in treating aortic stenosis, particularly in high-risk patients, trainings like these are essential. They ensure that cardiologists stay at the forefront of technological advancements and best practices in the field.

Aortic valve 59

Aortic valve Best Practices Interventional Cardiology Aortic 59

Dr. S. Venkatesan MD

JUNE 16, 2024

We must thank the technological innovators in the electro-anatomical mapping system, who are continuously upgrading and providing the best to us. This is what DC shocks do for temporary reversion to sinus rhythm ) How to localize the diastolic pathways ? How can we remember this EP lesson easily ?

Ablation 52

Ablation Physiology Technology Bicuspid/Mitral 52

Stroke Journal

FEBRUARY 1, 2024

Background:Advancements in arterial stenting technology have challenged prior notions favoring medical management over endovascular intervention for intracranial atherosclerotic disease (ICAD). Stroke, Volume 55, Issue Suppl_1 , Page ATP202-ATP202, February 1, 2024.

Stents 40

Stents Stent Technology Article 40

DAIC

MARCH 10, 2025

tim.hodson Mon, 03/10/2025 - 11:17 At the Cardiovascular Research Technologies (CRT) 2025 conference in Washington, D.C., The analysis of data from SCAARon the Prevail coronary paclitaxel drug-coated balloon (DCB) will be presented as a late-breaking clinical trial at Cardiovascular Research Technologies (CRT) 2025 in Washington, D.C.

Blood Pressure 52

Blood Pressure Aortic Medicare Hypertension 52

DAIC

JUNE 19, 2024

By the 1960s, advances in technology and medical research led to the emergence of automated ECG interpretation (AEI), based on physician-developed rules of classification. Research is also underway into algorithms for the diagnosis of Aortic Stenosis and Myocarditis and should be ready for commercialization in the next 18 – 36 months.

AFIB 105

AFIB Reimbursement Research Atrial Fibrillation 105

ADN Center of Excellence

SEPTEMBER 26, 2024

Looking Ahead As TAVI continues to evolve and play a crucial role in treating aortic stenosis, particularly in high-risk patients, trainings like these are essential. They ensure that cardiologists stay at the forefront of technological advancements and best practices in the field.

Aortic valve 52

Aortic valve Best Practices Interventional Cardiology Aortic 52